AstraZeneca
AZN
#53
Rank
NZ$494.24 B
Marketcap
NZ$318.69
Share price
0.09%
Change (1 day)
32.57%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): NZ$11.96

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$11.83. In 2024 the company made an earnings per share (EPS) of NZ$7.73 an increase over its 2023 EPS that were of NZ$6.54.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$11.96
2024NZ$7.7318.23%
2023NZ$6.5481.13%
2022NZ$3.61631.03%
2021NZ$0.49-88.11%
2020NZ$4.15136.89%
2019NZ$1.75-39.41%
2018NZ$2.89-28.27%
2017NZ$4.03-14.37%
2016NZ$4.7124.11%
2015NZ$3.80127.55%
2014NZ$1.67-51.96%
2013NZ$3.47-58.95%
2012NZ$8.46-32.2%
2011NZ$12.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.87 25.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.95 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.23-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.14-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.05 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.36-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$15.92 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.06-48.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.06-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.62-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK